Indaptus Therapeutics Inc

NASDAQ:INDP   12:56:01 PM EDT
5.77
-0.20 (-3.35%)
Earnings Announcements

Indaptus Therapeutics Reports Third Quarter 2021 Financial Results And Provides Corporate Update

Published: 11/15/2021 12:35 GMT
Indaptus Therapeutics Inc (INDP) - Indaptus Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update.
Q3 Loss per Share $0.81.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$1.80

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$2.44

More details on our Analysts Page.